Mydecine Innovations Group Announces Migration to NEO Exchange Post published:March 23, 2021 Post category:Press Release
Optimi Health Large Scale Multi-Purpose Mushroom Facility Advances Towards Completion and Licensing Post published:March 23, 2021 Post category:Press Release
Cybin Signs Drug Development Agreement with Catalent for its Fast-Dissolve Formulation of Novel, Deuterated Tryptamine (CYB003) Post published:March 22, 2021 Post category:Press Release
Mindset Pharma Announces $5 Million Bought Deal Financing Post published:March 22, 2021 Post category:Press Release
MindMed Announces Inclusion in FTSE Russell Indexes Post published:March 22, 2021 Post category:Press Release
Numinus Announces Closing of $40-Million Bought Deal Financing Post published:March 19, 2021 Post category:Press Release
Red Light Holland Closes Acquisition of SR Wholesale Becoming a Leader in Distribution of Psychedelics Post published:March 19, 2021 Post category:Press Release
Ty Tashiro joins MINDCURE as the Senior Translational and Psychometric Architect for iSTRYM’s AI-Driven Psychedelic Digital Therapeutic Technology Post published:March 19, 2021 Post category:Press Release
Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application Post published:March 19, 2021 Post category:Press Release